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bstract
A growing body of evidence implicates low membrane cholesterol in the pathogenesis of Alzheimer’s disease (AD). Here we show that
42 soluble oligomers accumulate more slowly and in reduced amount at the plasma membranes of PS-1L392V and APPV717I fibroblasts
rom familial AD (FAD) patients enriched in cholesterol content than at the counterpart membranes. The A42-induced production of reactive
xygen species (ROS) and the increase in membrane lipoperoxidation were also prevented by high membrane cholesterol, thus resulting in
higher resistance to amyloid toxicity with respect to control fibroblasts. On the other hand, the recruitment of amyloid assemblies to the
lasma membrane of cholesterol-depleted fibroblasts was significantly increased, thus triggering an earlier and sharper production of ROS
nd a higher membrane oxidative injury. These results identify membrane cholesterol as being key to A42 oligomer accumulation at the cell
urfaces and to the following A42-induced cell death in AD neurons.
2009 Elsevier Inc. All rights reserved.
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2. Introduction
Alzheimer’s disease (AD) is a progressive neurodegen-
rative disorder affecting the elderly that is characterized
y irreversible cognitive and physical deterioration. A com-
on feature of AD is the extracellular accumulation of the
40 and A42 peptides derived from the proteolytic cleav-
ge of the amyloid precursor protein (APP) carried out by
- and -secretase in the amyloidogenic pathway (Selkoe,
001; Citron et al., 1997; Takeda et al., 2004; Tabaton and
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el.: +39 055 4598320; fax: +39 055 4598905.
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oi:10.1016/j.neurobiolaging.2009.02.010amagno, 2007). Evidence for the relationship between the
evelopment of AD and abnormal A production also comes
rom the familial forms of AD (FAD). FAD only accounts
or about 5% of all AD cases, but the most significant FAD
utations are all associated with APP processing to yield A.
utosomal dominant forms of FAD are often characterized by
pecific mutations in the APP gene located on chromosome
1, or in the genes mapped on chromosomes 14 and 1, encod-
ng presenilin-1 (PS-1) and presenilin-2 (PS-2), respectively,
hich are components of a large protein complex respon-
ible for -secretase activity (Cruts and Van Broeckoven,
998). The amyloid cascade hypothesis causally links AD
linico-pathological process and neuronal cell death to the
ggregation and deposition of A (Selkoe, 2001). Neverthe-
ess, a recently modified “amyloid cascade hypothesis” for
D indicates that prefibrillar A40 and A42 oligomers, also
nown as amyloid -derived diffusible ligands (ADDLs),
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re the main responsible of cytotoxicity and synapse failure
Klein, 2002; Lacor et al., 2004).
A leading theory on the molecular basis of amyloid toxi-
ity suggests that amyloid unstable assemblies interact with
ell membranes destroying their ordered structure, eventu-
lly leading to membrane permeabilization with subsequent
lteration of ion homeostasis and intracellular redox sta-
us (Bokvist et al., 2004; Kayed et al., 2004; Stefani and
obson, 2003). Indeed we have recently described that amy-
oid oligomers exogenously added to the culture medium of
AD fibroblasts can readily insert into oxidative-damaged
PPV717I fibroblasts where the membrane integrity is com-
romised, resulting in a prompt increase in the production of
eactive oxygen species (ROS) (Cecchi et al., 2007). These
ata support the rising consensus on the role of membranes as
nitial triggers of the biochemical modifications culminating
ith cell death (Wakabayashi et al., 2005).
Recent studies have described a key role for membrane
holesterol in modulating A peptide production, clearance,
ggregation and neurotoxicity (Abad-Rodriguez et al., 2004;
azziotti and Perlmutter, 1998; Ledesma and Dotti, 2006;
hou and Richardson, 1996; Yip et al., 2001; Arispe and Doh,
002; Kawahara and Kuroda, 2001; Sponne et al., 2004). The
resence of cholesterol in neuronal membranes is known to
nduce large changes in membrane physical features such as
uidity and density of lipid packing resulting in alterations
f aggregate recruitment to the membrane and membrane
ermeabilization (Arispe and Doh, 2002; Mirzabekov et
l., 1996). In particular, it has been reported that the pres-
nce of cholesterol in artificial lipid bilayers inhibits the
hannel-forming activity of human amylin, A40, A42,
nd A25–35 peptides (Arispe and Doh, 2002; Chochina et
l., 2001; Mirzabekov et al., 1996; Lin and Kagan, 2002).
embrane cholesterol also interferes with neuronal apopto-
is induced by soluble oligomers of A peptide (Sponne et
l., 2004). On the other hand, reducing membrane cholesterol
akes the cell more vulnerable to the action of amyloid aggre-
ates (Arispe and Doh, 2002). Accordingly, we previously
eported a significant correlation between resistance to amy-
oid toxicity and membrane cholesterol content in various
ultured cell types (Cecchi et al., 2005).
It has recently been shown that seladin-1 gene, whose
roteic product catalyzes the last steps of cholesterol biosyn-
hesis (Waterham et al., 2001), appears to be down-regulated
n brain areas affected by AD (Greeve et al., 2000). Our
ecent findings also indicate that seladin-1-induced mem-
rane cholesterol enrichment protects SH-SY5Y cells against
myloid toxicity by reducing the interaction of A42
ligomer with cell membrane, featuring seladin-1 as a sus-
eptibility gene candidate for sporadic AD (Cecchi et al.,
008).
Here we carried out a study on cultured skin fibroblasts
rom FAD patients bearing either APP or PS-1 gene muta-
ions, and age-matched healthy control cells with increased
r diminished membrane cholesterol levels by cell culture
edia supplementation with water soluble cholesterol (PEG-
2
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holesterol) or methyl--cyclodextrin (-CD), respectively.
nder these conditions we investigated the dependence of
ell vulnerability to A42 aggregates on membrane choles-
erol content, by checking the extent of amyloid aggregate
nteraction with the cell membrane, oxidative stress and cell
eath markers in FAD fibroblasts compared to healthy cells.
e found that (i) membrane cholesterol enrichment sig-
ificantly reduces the interaction of A42 oligomers with
he cell membrane of FAD fibroblasts; on the other hand,
myloid aggregate interaction was significantly increased
n fibroblasts with reduced membrane cholesterol levels;
ii) membrane cholesterol enrichment significantly prevents
ntracellular ROS production and membrane lipoperoxida-
ion with respect to cholesterol-depleted cells; (iii) the higher
esistance to amyloid-induced oxidative stress in cholesterol-
nriched fibroblasts matched an improved cell viability.
lthough a direct link between alterations in the homeosta-
is of membrane cholesterol and AD pathogenesis is far from
een clear, our results support the idea that neuronal resis-
ance to A toxicity requires the maintenance of a proper
teady-state level of membrane cholesterol.
. Materials and methods
.1. Materials
All reagents were of analytical grade or the highest purity
vailable. Congo Red, fetal bovine serum (FBS), -CD,
olyoxyetanyl-cholesteryl sebacate (PEG-chol), vitamin E,
lipin III and other chemicals were from Sigma (Milan, Italy)
nless otherwise stated. 2′,7′-dichlorodihydrofluorescein
iacetate, acetyl ester (CM-H2DCFDA), 4,4-difluoro-
a,4adiaza-s-indacene (BODIPY 581/591 C11), wheat germ
gglutinin conjugated with fluorescein or with Alexa Fluor
33 and pluronic acid F127 were from Molecular Probes
Eugene, OR). CM-H2DCFDA and BODIPY 581/591 C11
ere prepared as stock solutions in dimethylsulfoxide
DMSO), purged with nitrogen and stored in light-protected
essels at −20 ◦C until use. A42 and A42-1 peptides, as
rifluoroacetate salts, were purchased from Bachem (Büben-
orf, Switzerland), A42 amine-reactive succinimidyl esters
f carboxyfluorescein (A42-FAM) was from AnaSpec
Simakova and Arispe, 2007). Lyophilized A42, A42-
AM and A42-1 were initially incubated in 1 mM in
exafluoro-2-propanol (HFIP) at least for 1 h at room tem-
erature to allow complete peptide monomerization (Lambert
t al., 2001). Then, aliquots of peptide solutions were dried
nder nitrogen and stored at −80 ◦C. Lyophilized amylin
–37 (Sigma, Milan, Italy) was stored and processed as pre-
iously reported (Cecchi et al., 2005)..2. Cell culture and treatment
In the present study we investigated nine fibroblast
ell lines. Fibroblasts were obtained from three patients
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elonging to Italian families bearing the APP Val717Ile
utation (mean ± SD age = 53.3 ± 7.1 years) and from three
atients belonging to other Italian families bearing the
S-1 Leu392Val and Met146Leu mutations (mean ± SD
ge = 56.7 ± 8.6 years), respectively. They underwent clini-
al assessment according to published guidelines and the AD
iagnosis fulfilled the Diagnostic and Statistical Manual of
ental Disorders criteria (DSM-IV) (American Psychiatric
ssociation, 1994; The Dementia Study Group of the Italian
eurological Society, 2000). Three age-matched healthy sub-
ects (mean ± SD age = 49.7 ± 8.3 years) were also analyzed.
he local ethical committee approved the protocol of the
tudy and written consent was obtained from all subjects
r, where appropriate, their caregivers. All control subjects
ere tested and none of them carried APP or PS-1 muta-
ions. These subjects were also carefully assessed with a
igorous diagnostic evaluation in order to exclude diagno-
is of other neurological disorders. Skin biopsies of 3 mm
unch were obtained from the volar side of the upper arm
f the FAD patients and healthy controls. The cells were
rown in Dulbecco’s modified Eagle’s medium (DMEM),
upplemented with 10% FBS, and harvested at confluence in
-25 flasks, 7 days after previous subculture (Cecchi et al.,
007). All fibroblast lines were subjected to an equal number
f passages (ranging from 10 to 18) and analyzed in three
ifferent experiments before confluence. Human SH-SY5Y
euroblastoma cells (ATCC, Manassas, VA) were cultured
n DMEM F-12 Ham with 25 mM HEPES and NaHCO3
1:1) supplemented with 10% FBS, 1.0 mM glutamine and
ntibiotics in a 5.0% CO2 humidified atmosphere at 37 ◦C
nd grown until 80% confluence. The increase in mem-
rane cholesterol content was achieved by supplementing
broblast culture media with 0.5 mM PEG-cholesterol for
h and neuroblastoma cell culture media with 0.1 mM PEG-
holesterol for 1 h at 37 ◦C. Membrane cholesterol depletion
as performed by incubating fibroblasts with 1.0 mM -
D for 2 h and neuroblastoma cells with 1.0 mM -CD for
0 min at 37 ◦C in the presence of 1% FBS. Then cells were
xtensively washed with phosphate buffered saline (PBS)
nd exposed to 1.0M A42 soluble oligomers obtained
ccording to Lambert’s protocol (Lambert et al., 2001). In an
ther set of experiments, APP fibroblasts were treated with
.0M fluorescein-labeled A42-FAM aggregates obtained
y Lambert’s protocol performed on a mixture of A42-
AM peptide with 2 molar equivalents of unlabeled A42
eptide (at ratio of 1:2) to minimize possible interference
f the fluorophore with the aggregation while retaining suf-
cient fluorescent signal. For fibrillar conditions, 10 mM
Cl was added to bring the peptide to a final concentra-
ion of 100M, and the peptide was incubated for 24 h at
7 ◦C (Dahlgren et al., 2002). Western blotting analysis of
42 soluble oligomers was performed on a Criterion XT
recast gel 4–12% Bis–Tris SDS/PAGE (Bio-Rad, Milan
taly), blotted onto a PVDF Immobilio-P Transfer Membrane
Millipore Corporation, Bedford, MA). The membrane was
locked in 1.0% (w/v) BSA in TBS-Tween (0.1% Tween
1
a
i
6f Aging 32 (2011) 210–222
0 in 20 mM Tris–HCl, pH 7.5, containing 100 mM NaCl)
nd incubated with 1:1000 diluted mouse monoclonal 6E10
nti-A antibodies (Signet, Dedham, MA) and then with
:5000 diluted peroxidase-conjugated anti-mouse secondary
ntibodies (Pierce, Rockford, IL, USA). The immunolabeled
ands were detected using a SuperSignal West Dura (Pierce,
ockford, IL, USA).
.3. Membrane cholesterol assay
The labeling of membrane cholesterol was investigated
y confocal scanning microscopy analysis, using the fluores-
ent probe filipin. Briefly, the cells seeded on glass coverslips
ere fixed in 4.0% buffered paraformaldehyde for 20 min at
◦C and then were incubated with 0.25 mg/ml cholesterol-
inding agent in PBS for 24 h at 37 ◦C. After washing, the
ells were fixed again in 4.0% buffered paraformaldehyde
or 20 min at 0 ◦C. Cell fluorescence was analyzed by a
onfocal Leica TCS SP5 scanning microscope (Mannheim,
ermany) equipped with an argon laser source for fluores-
ence measurements using emission lines at 510 nm for filipin
xcitation.
Cholesterol content was assayed in membrane fractions
sing the sensitive fluorimetric Amplex Red Cholesterol
ssay Kit (Molecular Probes, Eugene, OR), by comparison
ith a reference curve of cholesterol (0.01–1g) (Amundson
nd Zhou, 1999). Membrane fractions were obtained as pre-
iously described, with minor modifications (Cecchi et al.,
008). Briefly, cells were washed twice in PBS and dissolved
n PBS containing 9.0% sucrose, 0.1 mM phenylmethyl-
ulphonylfluoride (PMSF), 10g/ml leupeptin and 10g/ml
protinin prior to storage at −80 ◦C until use. Then, cells were
omogenized in PBS containing 9.0% sucrose with three
reeze–thaw cycles, 5 s sonication in ice. The samples were
entrifuged at 700 × g for 10 min at 4 ◦C and a further cen-
rifugation of the supernatant was performed at 110,000 × g
or 1 h at 4 ◦C to pellet the membrane fraction. Protein con-
ent in the membrane fractions was measured by the method
f Bradford (1976).
.4. Time-course of aggregate binding to the cell
embrane
The interaction of A42 aggregates with plasma mem-
ranes was monitored in FAD, healthy fibroblasts and SH-
Y5Y neuroblastoma cells seeded on glass coverslips by con-
ocal scanning microscopy as previously described (Cecchi
t al., 2007, 2008). Briefly, after treatment with 1.0M
42 prefibrillar aggregates for 30, 60, and 180 min, the
ells were counterstained with fluorescein-conjugated wheat
erm agglutinin (50g/ml) for 10 min to detect plasma mem-
rane profiles and fixed in 2% buffered paraformaldehyde for
0 min at room temperature. After plasma membrane perme-
bilization with a 3% glycerol solution, the coverslips were
ncubated for 60 min with 1:1000 diluted mouse monoclonal
E10 anti-A antibodies and then with 1:1000 diluted Texas
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ed-conjugated anti-mouse secondary antibodies (Vector
aboratories, DBA, Italy) for 90 min. Aggregate adsorp-
ion to the fibroblasts was also analyzed by cell treatment
ith 5.0M A42-FAM oligomers, counterstain of plasma
embranes with Alexa Fluor 633-conjugated wheat germ
gglutinin and fixing in 2% buffered paraformaldehyde, with-
ut plasma membrane permeabilization or using antibodies.
he fluorescence was analyzed by a confocal Leica TCS SP5
canning microscope (Mannheim, Germany) equipped with
n argon laser source for fluorescence measurements using
wo emission lines at 568m and 488 nm for Texas Red and flu-
rescein excitation, respectively. A series of optical sections
1024 × 1024 pixels) 1.0m in thickness was taken through
he cell depth at intervals of 0.5m using a Leica Plan Apo
3 × oil immersion objective and then projected as a sin-
le composite image by superimposition. The quantitation of
ggregate adsorption to the cell surface of FAD and healthy
broblasts was performed using the specific Congo Red dye
s previously described (Cecchi et al., 2007). Briefly, the same
umber of cells was treated for 10, 20, 30 and 60 min with
.0M A42 aggregates in a 96-well plate and then washed
wice with PBS. The residual aggregate-cell complex was
tained with 100l of 1.0M Congo Red in PBS for 20 min
t 37 ◦C and measured photometrically at 550 nm with an
LISA plate reader according to Datki et al. (2004). Congo
ed values are reported as percent increases with respect to
ntreated fibroblasts (assumed as 100%). For flow cytometric
nalysis of A42 binding, APP fibroblasts were incubated
n the cell culture medium containing 5.0M A42-FAM
ggregates, obtained as above reported, for 60 min and then
nalyzed by a FACSCanto (Beckton Dickinson Bioscences,
an Jose, CA).
.5. Evaluation of ROS production and intracellular
OS scavengers
FAD and healthy fibroblasts, representative of cholesterol
nrichment or depletion conditions, were cultured on glass
overslips and exposed to 1.0M A42 aggregates for 30,
0, and 180 min. As a negative control for oxidative stress,
broblasts were pre-treated with 100M vitamin E for 24 h
t 37 ◦C, before membrane cholesterol modulation and aggre-
ate exposure. Dye loading was achieved by adding to the cell
ulture media 5.0M ROS-sensitive fluorescent probe CM-
2DCFDA dissolved in 0.1% DMSO and pluronic acid F-127
0.01%, w/v) for 10 min at 37 ◦C. Then, the cells were fixed
nd the emitted CM-H2DCFDA fluorescence was detected at
88-nm excitation by a Leica Plan Apo 63 × oil immersion
bjective.
Intracellular hydrophilic ROS scavengers were measured
n cell lysates, obtained as previously reported (Cecchi et
l., 2005), of FAD and healthy fibroblasts exposed to 1.0M
42 aggregates for 3 h, by a chemiluminescence assay using
he photoprotein Pholasin (Abel Antioxidant Test Kit, Knight
cientific Limited, UK). The results were calculated using an
-ascorbic acid-based standard curve.
b
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.6. Analysis of lipoperoxidation
To assess the rate of lipid peroxidation, isoprostane lev-
ls were measured photometrically at 405 nm in the cell
ysates using the 8-isoprostane EIA kit (Cayman Chemi-
al Company, Ann Arbor, MI) following the manufacture’s
nstructions. Lipid peroxidation after cell aggregate expo-
ure was also investigated by confocal scanning microscopy
nalysis, using the fluorescent probe BODIPY 581/591 C11,
s previously described (Pensalfini et al., 2008). In particu-
ar, BODIPY 581/591 C11 by mimicking the properties of
atural lipids (Naguib, 1998) can be used to measure antiox-
dant activity in lipid environments since it is behaves as
fluorescent lipid peroxidation reporter that shifts its flu-
rescence from red to green when challenged with oxidizing
gents (Drummen et al., 2004). Briefly, fibroblasts, repre-
entative of cholesterol enrichment or depletion conditions,
ere cultured on glass coverslips and exposed 1.0M A42
ggregates for 3 h at 37 ◦C. As a negative control, fibrob-
asts were pre-treated with 100M vitamin E for 24 h at
7 ◦C, before membrane cholesterol modulation and aggre-
ate exposure. Dye loading was achieved by adding to the
ell culture media the fluorescent probe BODIPY dissolved
n 0.1% DMSO (5.0M final concentration) for 30 min at
7 ◦C. The cells were fixed in 2% buffered paraformaldehyde
or 10 min at room temperature and the BODIPY fluores-
ence was detected at 581-nm excitation by collecting the
mitted fluorescence with a Leica Plan Apo 63 × oil immer-
ion objective as above reported.
.7. Amyloid cytotoxicity assay
Aggregate cytotoxicity to FAD and healthy fibroblasts
as assessed in 96-well plates by the 3-(4,5-dimethylthiazol-
-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as
reviously reported (Cecchi et al., 2007). Briefly, after the
xposure to 1.0M A42 monomers, oligomers or fibrils or
o A42-1 reversed sequence peptide or amylin for 24 h at
7 ◦C, the cell cultures were incubated with 0.5 mg/ml MTT
olution at 37 ◦C for 4.0 h and with cell lysis buffer (20% SDS,
0% N,N-dimethylformamide, pH 4.7) overnight. As a neg-
tive control for oxidative stress, fibroblasts were pre-treated
ith 100M vitamin E for 24 h at 37 ◦C, before membrane
holesterol modulation and aggregate exposure. Absorbance
alues of blue formazan were determined at 590 nm using
n ELISA plate reader. Cell viability was expressed as per-
ent of MTT reduction in treated cells as compared to
ounterpart untreated cells, where it was assumed as 100%.
oreover, the effect of aggregate treatments on cell mor-
hology was investigated by Hoechst 33342 dye staining.
riefly, fibroblasts treated as above reported were incubated
ith 20g/ml Hoechst for 15 min at 37 ◦C and fixed 2%
uffered paraformaldehyde for 10 min at room temperature.
lue fluorescence micrographs of cells were obtained under
V illumination in an epifluorescence inverted microscope
Nikon, Diaphot TMD-EF) with an appropriate filter set.
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inally, lactate dehydrogenase (LDH) release into the cul-
ure media, a typical necrotic marker, was measured after cell
xposure to 1.0M A42 aggregates or to A42-1 reversed
equence peptide for 48 h at 37 ◦C by the LDH assay kit
Roche Diagnostics, Mannheim, Germany) at 490 nm after
lank subtraction at 595 nm.
.8. Statistical analysis
All data were expressed as mean values ± standard devia-
ion (SD). The comparisons among the different groups were
erformed by ANOVA followed by Bonferroni’s t-test. A
-value less than 0.05 was accepted as statistically significant.
. Results
.1. Membrane cholesterol enrichment reduces Aβ
ggregate binding to the cell membrane
Cell degeneration in amyloid diseases appears to be medi-
ted by a toxic mechanism involving some interaction of
he aggregated species with the plasma membrane of the
ffected cells (Bokvist et al., 2004; Kayed et al., 2004; Stefani
nd Dobson, 2003). We previously showed that A42 aggre-
ates accumulate quicker near the plasma membrane in FAD
broblasts than in wild-type cells possibly as a result of
ncreased membrane lipoperoxidation (Cecchi et al., 2007).
ere, we investigated the dependence of the membrane-
inding capacity of A42 soluble oligomers (Fig. 1a) on
embrane cholesterol content in PS-1, APP and wild-type
broblasts. In particular, we induced modifications of mem-
rane cholesterol content by incubating FAD and healthy
broblasts in the presence of either PEG-cholesterol or -
e
r
o
o
ig. 1. Modulation of membrane cholesterol in FAD and healthy fibroblasts. (a) Rep
y SDS/PAGE on a 4–12% criterion XT Precast Bis–Tris gel and probed with mono
ntibodies. (b) Representative confocal microscopy analysis of membrane choleste
embrane cholesterol enrichment was achieved by incubating WT, PS-1 and APP fi
holesterol depletion was performed by adding 1.0 mM -CD for 2 h at 37 ◦C in the
xidase, as described in Section 2. The reported values are representative of three ind
ells with basal cholesterol levels.f Aging 32 (2011) 210–222
D followed by extensive washing with PBS. As shown
n Fig. 1b, a morphological evaluation of FAD and healthy
broblasts by confocal microscopy revealed a clear modula-
ion of membrane cholesterol content under our experimental
onditions. Quantitative analysis confirmed that cell expo-
ure to soluble cholesterol resulted in a significant increase
n membrane cholesterol (about 20%) vs respective control
ells in all investigated fibroblast lines (Fig. 1b). Conversely,
broblasts treated with -CD underwent a significant reduc-
ion in membrane cholesterol (about 25%) vs counterpart
broblasts. The increase in plasma membrane cholesterol
esulted in a reduced amyloid-binding capacity to the plasma
embrane of FAD fibroblasts with respect to relative cells,
s assessed by confocal microscopy analysis of cells exposed
or 30, 60 and 180 min to A42 aggregates (Fig. 2a).
ccordingly, the Congo Red assay showed that cell media
upplementation with soluble cholesterol resulted in a signif-
cant reduction of A42 aggregate binding to the cell plasma
embranes with respect to controls (Fig. 2b). On the other
and, in fibroblasts from healthy subjects just few aggregates
ollowing longer time of protein exposure can be observed
Fig. 2a). Conversely, the same amyloid oligomers added to
he cell culture medium appear to accumulate more rapidly
nd to a greater extent at the plasma membrane in -CD
reated cells characterized by a reduced content of cholesterol
han in counterpart cells (Fig. 2a and b). Furthermore, A42
ssemblies share a more rapid kinetic of interaction with cell
urfaces in APP than in PS-1 fibroblasts. No significant dif-
erence in Congo Red absorbance values between wild-type
nd FAD groups of A42-untreated cells was observed. An
qual cell number from cultures with a comparable division
ate from different donors were exposed to the aggregates in
rder to exclude the influence of these factors on the amount
f A bounded to the cell surface. The ability of exposed cells
resentative Western blotting analysis of A42 soluble oligomers separated
clonal mouse 6E10 antibodies and with peroxidase-conjugated anti-mouse
rol in WT, PS-1 and APP fibroblasts probed by the fluorescent dye filipin.
broblasts with 0.5 mM PEG-cholesterol (Chol) for 2 h at 37 ◦C; membrane
culture media. The amount of cholesterol was determined using cholesterol
ependent experiments. *Significant difference (p≤ 0.05) vs relative control
A. Pensalfini et al. / Neurobiology of Aging 32 (2011) 210–222 215
Fig. 2. Increasing cell cholesterol reduces A aggregate binding to the cell membrane. (a) Confocal microscopy images show aggregates penetrating into the
plasma membrane of wild-type, PS-1 and APP fibroblasts under different experimental conditions. After treatment for 0, 30, 60 and 180 min with 1.0M A42
aggregates, counterstaining was performed with fluorescein-conjugated wheat germ agglutinin to detect plasma membrane profile (green). The aggregates were
labeled with monoclonal mouse 6E10 anti-A antibodies and Texas Red-conjugated anti-mouse secondary antibodies with plasma membrane permeabilization
with glycerol, as specified in Section 2. (b) Time-course of amyloid aggregate binding to PS-1 and APP fibroblasts. After the exposure to 1.0M A42
aggregates for 0, 10, 20, 30, 60 min, cells were washed and the residual aggregate-cell complex was stained with 1.0M Congo Red for 20 min. Under these
c gates a
r e. *Sign
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epresentative of three independent experiments each carried out in triplicat
evels. (For interpretation of the references to color in this figure legend, the
o bind A aggregates appeared saturable, reaching its limit
n the first 30–60 min (Fig. 2b). Moreover, the red fluores-
ence signals related to 6E10 antibody, that recognizes also
he full length human APP, are negligible in all the analyzed
onditions before A treatment (see time 0). This evidence let
s to rule out the possibility that the differences in the accu-
ulation of exogenous A at the cell surface were due to
ifferent levels of APP expression or to the presence of APP
utant forms in these cells. In order to exclude the contribute
f intracellular A to 6E10 red signals, a set of experi-
ents was carried out in the same experimental conditions
ith fluorescein-labeled A42-FAM aggregates. Confocal
icroscopy images of fibroblasts treated with A42-FAM
ggregates also confirmed the idea that the ability of A42
ggregates to bind to the plasma membrane is significantly
ffected by its content in cholesterol (Fig. 3a). The staining
rofile of APP fibroblasts exposed to A42-FAM aggregates
etained a less fluorescent signal compared to images shown
n Fig. 2a, since to minimize fluorophore interference with
he aggregation process, the oligomers were prepared by mix-
o
t
p
tdsorbed to cell membrane surface. The reported values (means ± SD) are
ificant difference (p≤ 0.05) vs relative control cells with basal cholesterol
is referred to the web version of the article.)
ng just one A42-labeled molecule with two equivalents of
42-unlabeled peptide. Amyloid binding to APP fibrob-
asts, as a function of membrane cholesterol content, was
lso quantified by flow cytometric analysis. Histograms illus-
rating the distribution for A42-FAM-positive fibroblasts
re shown in Fig. 3b. A higher percentage of fluorescent-
ositive cells (+42%) in fibroblasts with low membrane
holesterol with respect to controls was evident, as indicated
y the shift of the distribution curve toward higher intensity
evels. On the other hand, the increase in membrane choles-
erol resulted in a lower percentage of fibroblasts (−39%)
ith surface-binding affinity toward fluorescent A42-FAM
ggregates.
To make these data more relevant, we extended
ur study to human SH-SY5Y neuroblastoma cells in
asal condition (10.84 ± 0.54g membrane cholesterol/mg
f protein), in cells significantly enriched in choles-
erol content (13.55 ± 0.68g membrane cholesterol/mg of
rotein;p≤ 0.01) and in cells significantly depleted in choles-
erol content (8.26 ± 0.73g membrane cholesterol/mg of
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Fig. 3. A aggregate binding inversely correlates with membrane choles-
terol content. (a) Confocal microscopy images show fluorescein-labeled
A42-FAM aggregates (green) penetrating into the plasma membrane of
APP fibroblasts with different membrane cholesterol content. Membrane
profile was counterstained with Alexa Fluor 633-conjugated wheat germ
agglutinin (red). (b) Flow cytometry analysis of A42-FAM binding to APP
fibroblasts after treatment for 60 min with 1.0M A42 aggregates in basal
(solid line), in cholesterol-depleted (dotted line) and in cholesterol-enriched
conditions (thinner solid line) (see Section 2 for details). Histograms of the
number of cells vs A42-FAM fluorescence. Fluorescent gates were used to
separate cells with lower A42-FAM binding affinity and cells with higher
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Fig. 4. Membrane cholesterol modulates A aggregate binding to human
SH-SY5Y neuroblastoma cells. Representative confocal microscopy images
showing aggregates penetrating into the plasma membrane of neuroblastoma
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t42-FAM binding affinity with respect to control cells. (For interpretation
f the references to color in this figure legend, the reader is referred to the
eb version of the article.)
rotein; p≤ 0.01). According to fibroblast data, the increase
n plasma membrane cholesterol resulted in a reduced A
ligomer binding to the plasma membrane in human neurob-
astoma cells as detected by confocal microscopy analysis
sing monoclonal anti-A antibodies (Fig. 4). On the other
and, the same oligomers added to the neuroblastoma cul-
ure medium appeared to accumulate to a greater extent at
i
A
(
tells after cell treatment for 0 or 1 h with 1.0M A42 aggregates in basal
onditions, in cholesterol enriched cells (Chol) and in cholesterol-depleted
ells (-CD) (see Section 2 for details).
he plasma membrane in -CD treated cells characterized by
educed membrane cholesterol content.
.2. Membrane cholesterol enrichment reduces ROS
roduction and ROS scavenger impairment
There is strong experimental evidence that oxidative stress
s an early biochemical modification in cells facing amyloid
ggregates (Butterfield et al., 2007). Therefore, we inves-
igated the dependence of ROS production on membrane
holesterol content in human fibroblasts exposed to amy-
oid aggregates. A time-course analysis showed that in APP
nd, to a lesser extent, in PS-1 fibroblasts an earlier and
harper increase in intracellular ROS content than in wild-
ype fibroblasts (Fig. 5a). The reduced ability of APP cells
o counteract A42 aggregate oxidative attack was also
onfirmed by a significant impairment in intracellular ROS
cavengers with respect to that observed in PS-1 and wild-
ype fibroblasts. Indeed, ROS scavengers were significantly
ifferent among the investigated fibroblast lines with basal
holesterol content (1500 ± 52 nmol ascorbate/mg of pro-
eins in wild-type, 1170 ± 39 nmol ascorbate/mg of proteins
n PS-1, and of 821 ± 49 nmol ascorbate/mg of proteins in
PP fibroblasts), according to our previous reported data
Cecchi et al., 2002). Interestingly, PEG-cholesterol addi-
ion to the cell culture media was as effective as vitamin
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Fig. 5. Cholesterol enrichment reduces A42-induced ROS production and ROS scavenger weakening. (a) Representative confocal images of intracellular
ROS levels in WT, PS-1 and APP fibroblasts under different experimental conditions. After treatment for 0, 30, 60 and 180 min with 1.0M A42 prefibrillar
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egative control. For details see Section 2. (b) Intracellular ROS scavengers
chemiluminescent assay and expressed in ascorbate-equivalent units. The
ach carried out in triplicate. *Significant difference (p≤ 0.05) vs relative u
in reducing ROS production induced by A aggregates
ith respect to relative cells with basal cholesterol content
Fig. 5a). Moreover, the impairment of ROS scavengers was
ess in cholesterol-enriched FAD cells, matching the almost
omplete prevention of aggregate-induced oxidative stress
btained by pre-incubating the cells with 100M vitamin E.
onversely, loss in membrane cholesterol, resulting from cell
reatment with -CD, induced a greater increase in intracel-
ular ROS production and consumption of ROS scavengers
Fig. 5a and b). Notably, PEG-cholesterol and -CD expo-
ure do not induce ROS production in amyloid untreated
broblasts, as we can see at time 0 (Fig. 5a).
.3. Membrane cholesterol enrichment reduces Aβ
ggregate-induced lipoperoxidation
Membrane lipoperoxidation after aggregate exposure was
nalyzed by confocal microscopy analysis using the fluo-
escent probe BODIPY. The red fluorescence observed in
asal cholesterol and in -CD cholesterol-depleted fibrob-
asts from healthy subjects shifted to green after 3 h of
b
e
t
aent probe CM-H2DCFDA and then fixed. Vitamin E (Vit E) was used as
ssessed in cell lysates, after 3 h of exposure to 1.0M A42 aggregates by
values (means ± SD) are representative of three independent experiments
cells.
myloid aggregate exposure (Fig. 6a). According to previous
eported data (Cecchi et al., 2002), PS-1 and, to a greater
xtent, APP fibroblasts showed a basal oxidative-stressed
ondition, as revealed by the orange fluorescence in untreated
broblasts. Anyway, the fluorescence signals observed in
embrane cholesterol-enriched cells exposed to A42 aggre-
ates did not significantly differ from their respective in
ntreated cells, confirming a fair protective role of mem-
rane cholesterol in FAD cells. Similar experiments carried
ut in the presence of vitamin E on all investigated fibroblast
ines confirmed the specificities of the fluorescence signals.
oreover, we measured the levels of 8-OH isoprostanes, as
uantitative lipoperoxidation marker. As shown in Fig. 6b,
soprostanes were significantly higher in APP than in PS-1
broblasts, since at a basal level. Cellular isoprostane lev-
ls were further increased following A42 exposure both in
ells with basal and, to a greater extent, with reduced mem-
rane cholesterol content. Conversely, membrane cholesterol
nrichment was effective in reducing isoprostane produc-
ion like as vitamin E in FAD fibroblasts treated with A42
ggregates compared to relative control cells.
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Fig. 6. Cholesterol enrichment protects FAD fibroblasts from A42 peptide-induced lipoperoxidation. (a) Representative confocal microscopy images of lipid
peroxidation in WT, PS-1 and APP fibroblasts under different experimental conditions. Cells were treated with 1.0M A42 for 3 h, with or without vitamin E
(Vit E), and lipid peroxidation was measured using the fluorescent probe BODIPY as a probe according to Section 2. (b) Lipid peroxidation was also measured
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.4. High membrane cholesterol prevents Aβ aggregate
ytotoxicity
Next we investigated whether changes in oxidative mark-
rs also resulted in modulation of A aggregate toxicity to
xposed cells. As shown in Fig. 7a, morphological evaluation
f healthy and FAD fibroblasts using Hoechst 33342 staining
evealed no marked characteristics of apoptosis (i.e. nuclear
ondensation or DNA fragmentation) in cells enriched
n membrane cholesterol after 24 h of exposure to A42
ggregates with respect to similarly exposed control cells
ith basal cholesterol content. Accordingly, as revealed by
he MTT assay (Fig. 7b), both FAD and wild-type fibroblasts
ith cholesterol-rich membrane were significantly more
esistant to A42 aggregate toxicity with respect to simi-
arly exposed control cells with basal cholesterol content.
onversely, loss in membrane cholesterol, following cell
reatment with -CD, resulted in a significant increase
n the number of cells showing nuclear condensation, as
evealed by the increase in Hoechst fluorescence (Fig. 7a),
n
fi
a
O(means ± SD) are representative of three independent experiments carried
difference (p≤ 0.05) vs relative untreated cells.
nd in a significant impairment of cell viability (Fig. 7b)
pon exposure to the aggregates. Cell treatment with PEG-
holesterol or -CD do not affect cell viability (data not
hown). Vitamin E and A42-1 reversed sequence peptide
ere used as negative controls. In particular, the absence
f any cytotoxic effect in A42-1 treated cells highlighted
he selectivity of the cellular response to A42 peptide
ggregates. Moreover, the selectivity of the cytoprotective
ole of high membrane cholesterol was investigated in cells
xposed to different forms of A42 aggregates and to amylin
refibrillar aggregates (Fig. 8). Under our experimental con-
itions, cholesterol-depleted fibroblasts showed an apparent
usceptibility to the A42 mature fibrils, but to a lesser extent
han to A42 oligomers. In any case, A42 fibrils induced a
ore evident DNA damage in APP than in PS1 fibroblasts.
n the other hand, cholesterol-enriched fibroblasts displayed
o significant change of cell viability upon exposure to A42
brils, suggesting that membrane cholesterol enrichment
lso protects cells from perturbation by fibrillar aggregates.
verall, FAD fibroblasts exposed to fibrils displayed variable
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Fig. 7. Cholesterol enrichment prevents A aggregate toxicity. (a) The toxic
effect of A42 aggregates on FAD and healthy fibroblast morphology was
evaluated using the Hoechst 33342 dye staining. Representative blue fluores-
cence micrographs of untreated (−A42) or exposed fibroblasts to 1.0M
A42 aggregates for 24 h (for details see Section 2). (b) Cell viability was
checked by the MTT reduction test in cells treated with 1.0M A42 aggre-
gates for 24 h. The reported values (means ± SD) are representative of four
independent experiments, each performed in triplicate. (c) Fibroblast via-
bility was checked by LDH release into the culture medium after exposure
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Fig. 8. Cholesterol protects against A fibrils and amylin aggregate toxic-
ity. The toxic effect of 1.0M A42 monomers (A42 M), A42 oligomers
(A42 O), A42 fibrils (A42 F) and amylin aggregates on FAD fibroblasts
was evaluated using Hoechst 33342 dye staining. Representative blue flu-
orescence micrographs of PS-1 and APP fibroblasts exposed to different
forms of A42 or amylin prefibrillar aggregates for 24 h. Cell viability was
checked by the MTT reduction test in PS-1 and APP fibroblasts exposed to
t
p
(
b
b
w
fo 1.0M A42 aggregates for 48 h. The values shown are means ± SD of
hree independent experiments, each performed in triplicate. *Significant
ifference (p≤ 0.05) vs relative untreated cells.
usceptibility to damage and to apoptotic death, confirming
significant inverse relation to membrane content in
holesterol. A reduced vulnerability to the stress induced by
mylin oligomers was also observed in cholesterol-enriched
broblasts with respect to cells with low cholesterol content,
urther supporting the generality of these effects. On the other
and, a negligible cytotoxicity after treatment with A42
onomeric peptide further tightly linked previous results to
he -sheet structure found in A42 and amylin aggregates.
Thought displaying the typical features of apoptotic cells,
AD and wild-type fibroblasts with basal and reduced mem-
t
L
w
the same aggregates. The reported values are representative of three inde-
endent experiments, each performed in duplicate. *Significant difference
p≤ 0.05) vs relative untreated cells.
rane cholesterol content appeared to be similarly affected
y 24 h of A42 aggregate exposure. Then, we investigated
hether fibroblasts exposed to A42 prefibrillar aggregates
or longer times (48 h) underwent a necrotic, rather then apop-
otic, cell death. As shown in Fig. 7c, a significant release of
DH in the cell culture media was observed in fibroblasts
ith basal and, to a greater extent, reduced cholesterol con-
ent exposed to A aggregates. Again, cholesterol enriched
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broblasts displayed a higher resistance to amyloid toxic-
ty, compared to relative control cells, as revealed by the
ignificant reduction of LDH release into the culture media.
. Discussion
Growing data indicate that changes in membrane choles-
erol content, by modulating lipid fluidity, have regulatory
onsequences for A interactions with the cell plasma mem-
ranes and neurotoxicity (Mazziotti and Perlmutter, 1998;
edesma and Dotti, 2006; Zhou and Richardson, 1996; Yip
t al., 2001; Arispe and Doh, 2002; Sponne et al., 2004;
hochina et al., 2001; Cecchi et al., 2008). The present study
rovides evidence supporting the hypothesis that membrane
holesterol modulation might affect the sensitivity to A42
ggregates of primary fibroblasts carrying APP Val717Ile or
S-1 Leu392Val or Met146Leu gene mutations by modulat-
ng A aggregate binding to the cell membrane, recognized
s a primary step in amyloid cytotoxicity. In particular,
onfocal microscopy images, flow cytometric analysis and
ongo red assay revealed that A42 assemblies accumu-
ate faster, and are internalized to a greater extent into, the
lasma membranes of cholesterol-poor fibroblasts than in
holesterol-enriched cells. Indeed, it seems likely that when
he level of cholesterol in the membrane is higher than nor-
al, the insertion process can be prevented by the enhanced
tiffness of the membrane. On the other hand, when the A
ligomer encounters a membrane with increased fluidity due
o a lower cholesterol level, the insertion process can occur
Arispe and Doh, 2002). Despite a relatively low number of
atient samples employed in our study that limits the sta-
istical power of the results, these findings strongly support
he idea that the ability of A42 aggregates to bind to the
lasma membrane is significantly affected by its content in
holesterol (Cecchi et al., 2005). Even in human SH-SY5Y
euroblastoma cells, mild cholesterol enrichment appears
o prevent A42 aggregate binding to the plasma mem-
rane, corroborating our hypothesis in a neuronal system.
owever, it cannot be excluded that different APP distri-
ution and/or accessibility in the plasma membranes, likely
esulting from lipid raft reorganization at the different exper-
mental conditions used, may contribute to the interaction of
he A aggregates with the cell membranes. Indeed, recent
vidence suggests that A interacts with the APP present
t the cell surface and acts as a ligand of its own precur-
or, resulting in a cell death-related signal (Shaked et al.,
006). Oxidative stress has largely been implicated as a major
ause of neurotoxicity in AD and there is strong evidence
inking lipid peroxidation and amyloid plaques within the
D brain (Canevari et al., 2004; Lovell and Markesbery,
006; Subbarao and Richardson, 1990; Squier, 2001; Floyd
nd Hensley, 2002). Oxidative damage, possibly induced
y A, may further exacerbate A toxicity by modulating
he A amyloid pathway (Crouch et al., 2007). Indeed, A
s reported to accumulate faster in membranes containing
p
(
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xidatively damaged phospholipids than in membranes con-
aining only unoxidized or saturated phospholipids (Murray
t al., 2007). We have previously shown a marked increase
n oxidation levels of lipids and proteins in peripheral cells
rom some FAD patients (Cecchi et al., 2002). Moreover, we
ave described that amyloid oligomers can readily insert into
xidative-damaged APPV717I fibroblasts where the mem-
rane integrity is compromised (Cecchi et al., 2007). The
arly appearance of amyloid aggregates bounded to fibrob-
ast surfaces therefore suggests that these species are the main
ource of oxidative stress for cells. Actually, cholesterol-
oor cells displayed a prompt and enhanced ROS increase
pon aggregate binding to the cell membrane with respect
o control fibroblasts with basal membrane cholesterol con-
ent. Conversely, membrane cholesterol enrichment resulted
n a delayed and significantly reduced rise of ROS produc-
ion in the affected PS-1 and APP fibroblasts exposed to
 aggregates. In these cellular models the protective role
f membrane cholesterol against amyloid oxidative dam-
ge seem particularly hopeful. Our approach allows to study
he potential defensive role of a mild membrane choles-
erol enrichment against A-induced cytotoxicity in living
ells having a genetic drawback in tissues where AD lesions
ccur. Indeed, mutated fibroblasts displayed a lower level
f basal ROS scavengers, thus suggesting that a modified
edox status is a common feature of cells carrying these
enetic lesions. This evidence could reflect chronic expo-
ure to an oxidizing environment in mutated fibroblasts with
continuous overproduction of amyloid peptide. Several
tudies provide evidence for excess lipoperoxidation and
rotein oxidation associated with A deposits in APP and
S-1 AD brain and mutant mice (Butterfield et al., 2007;
anevari et al., 2004). Accordingly, the reported confocal
icroscopy images and the quantitative analysis of 8-OH
soprostane levels show that A42 aggregates added to the
ell culture media induce a more extensive lipoperoxida-
ion and membrane oxidative injury in APP than in PS-1
utated fibroblasts. Nevertheless, cholesterol-enriched FAD
broblasts appear more resistant to amyloid oxidative attack
ith respect to control cells with basal membrane choles-
erol. On the other hand, membrane cholesterol depletion
trongly exacerbates A-induced lipid peroxidation. These
esults therefore suggest that membrane cholesterol con-
ent negatively correlates with lipoperoxidant effects on
olyunsaturated fatty acids in cell membrane phospholipids
nduced by A42 oligomers. Membrane cholesterol enrich-
ent cannot completely revert A42 oxidative damage in
PP mutated fibroblasts, suggesting that other important
actors are involved in A42 aggregate binding to cell mem-
ranes. Our previous findings provided compelling evidence
hat mutated fibroblasts bearing increased membrane lipoper-
xidation are more susceptible to aggregate binding to the
lasma membrane and to the resulting amyloid toxicity
Cecchi et al., 2007).
This study indicates that membrane cholesterol can read-
ly modulate FAD fibroblasts sensitivity to A-induced
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xidative attack. In particular, membrane cholesterol enrich-
ent resulted in almost complete recovery of mitochondrial
unction and in a significant reduction of LDH release into
he culture media of exposed FAD fibroblasts according to
revious data on SH-SY5Y cells, PC12 cells and rat embryo
ortical neurons (Yip et al., 2001; Arispe and Doh, 2002;
ponne et al., 2004). On the other hand, cell sensitivity to
he cytotoxic effect of A42 aggregates was significantly
nhanced by low cholesterol levels. Remarkably, amylin
reatment of low cholesterol fibroblasts affects cell viabil-
ty resembling A42 outcome. These data suggest that the
odification of membrane cholesterol is generally able to
odulate the toxic effect of amyloidogenic peptides inde-
endently from their amino acid sequence. Moreover, our
ata are consistent with increasing evidence that oligomeric
ggregates, compared to mature fibrils, are likely the more
oxic species of amyloid peptides (Cecchi et al., 2007; Kayed
t al., 2004; Klein, 2002; Lacor et al., 2004; Stefani and
obson, 2003). We can therefore conclude that the presence
f -sheet structure seems to be stringent for the mem-
rane perturbing properties of A oligomers. A moderate,
ut significant increase of cell resistance to fibril toxicity in
broblasts with higher membrane cholesterol is likely to be
he result of binding inhibition of minute amounts of residual
refibrillar aggregates, although a specific modulation of the
oxic effect of the fibrils cannot be ruled out. It has recently
een shown that seladin-1 gene, whose proteic product cat-
lyzes the last steps of cholesterol biosynthesis (Waterham
t al., 2001), appears to be down-regulated in brain areas
ffected by AD (Greeve et al., 2000). Our recent findings
lso indicate that seladin-1-induced membrane cholesterol
nrichment protects SH-SY5Y cells against amyloid toxic-
ty by reducing the interaction of A42 oligomer with cell
embrane, featuring seladin-1 as a susceptibility gene can-
idate for sporadic AD (Cecchi et al., 2008). In this view
ne might propose that, by modulating the membrane fluid-
ty, plasma membrane cholesterol content may specifically
nfluence APP processing and A production as well as the
nsertion of soluble A in the phospholipid bilayer and its
roperties to disturb the membrane structure which ultimately
rigger cell death.
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